• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom, Companion Medical will share glucose, insulin data

June 7, 2019 By Nancy Crotti

Dexcom (NSDQ:DXCM) and Companion Medical have announced a collaboration to enable a direct exchange of continuous glucose monitoring (CGM) data from Dexcom with insulin data from InPen into both companies’ software applications.

Companion made a partnership deal with Glooko this week to integrate data from its InPen smart insulin injection pen into Glooko’s diabetes data management system and mobile application.

Dexcom and Companion Medical said they are working on developing a seamless data transfer of both insulin and glucose information to improve in-the-moment decisions for those managing their diabetes with multiple daily injections. Advanced decision support requires multiple inputs, including current glucose, glucose trend, carbohydrate intake, accurate insulin dosing and insulin-on-board.

Dexcom and Companion Medical will initially enable InPen users to display long-acting and rapid-acting insulin data in the Dexcom Clarity Diabetes Management Software. Dexcom CGM data is currently available in the Companion Medical Insights by InPen report. This integration enables health care providers to access a combined, comprehensive view of a patient’s therapy plan, increasing the effectiveness of how and when patients should dose and paving the way for improved and transparent treatment decisions, the companies said.

The InPen/Clarity report integration will be launched and available for preview at the  American Diabetes Association conference, which runs today through Wednesday, June 12, in San Francisco. Both companies said they are actively developing their real-time integrated systems.

“These decisions are synchronous to the person living with diabetes, which provides a compelling opportunity for our teams to work together,” said Steve Pacelli, EVP of strategy and corporate development for Dexcom, in a news release.

“Improving outcomes for people on multiple daily injections requires bringing together the two critical factors of diabetes management — glucose and insulin — in real-time. We are the first two companies with the technology capable of providing an integrated solution,” added Companion Medical CEO Sean Saint.

 

Filed Under: Business/Financial News, Diabetes, Featured, Wall Street Beat Tagged With: American Diabetes Association, Companion Medical, DexCom Inc., glooko

IN CASE YOU MISSED IT

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance
  • Rapid Dose closes first tranche of $5M financing

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS